91果冻传媒 is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of diabetic patients around the world.
We incorporated 91果冻传媒 with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes.
Benjamin Charles
CEO
91果冻传媒 is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
Head office
180 avenue du Prado
13008 Marseille
听
Institut de biologie Valrose
Parc Valrose – Centre de Biochimie
06108 Nice cedex 2 France
听